Matches in Wikidata for { <http://www.wikidata.org/entity/Q61448032> ?p ?o ?g. }
Showing items 1 to 81 of
81
with 100 items per page.
- Q61448032 description "im Januar 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q61448032 description "scholarly article by Lorie A Ellis et al published 2019 in ClinicoEconomics and Outcomes Research" @default.
- Q61448032 description "wetenschappelijk artikel" @default.
- Q61448032 description "наукова стаття, опублікована у 2019" @default.
- Q61448032 name "Comparative analysis of US real-world dosing patterns and direct infusion-related costs for matched cohorts of rheumatoid arthritis patients treated with infliximab or intravenous golimumab" @default.
- Q61448032 name "Comparative analysis of US real-world dosing patterns and direct infusion-related costs for matched cohorts of rheumatoid arthritis patients treated with infliximab or intravenous golimumab" @default.
- Q61448032 type Item @default.
- Q61448032 label "Comparative analysis of US real-world dosing patterns and direct infusion-related costs for matched cohorts of rheumatoid arthritis patients treated with infliximab or intravenous golimumab" @default.
- Q61448032 label "Comparative analysis of US real-world dosing patterns and direct infusion-related costs for matched cohorts of rheumatoid arthritis patients treated with infliximab or intravenous golimumab" @default.
- Q61448032 prefLabel "Comparative analysis of US real-world dosing patterns and direct infusion-related costs for matched cohorts of rheumatoid arthritis patients treated with infliximab or intravenous golimumab" @default.
- Q61448032 prefLabel "Comparative analysis of US real-world dosing patterns and direct infusion-related costs for matched cohorts of rheumatoid arthritis patients treated with infliximab or intravenous golimumab" @default.
- Q61448032 P1433 Q61448032-CFC43FAD-5F93-4BF7-BF69-080DA00E2218 @default.
- Q61448032 P1476 Q61448032-5B8E6B7B-6373-4B46-91AD-2BED8D0B648B @default.
- Q61448032 P2093 Q61448032-06B950AC-CBDE-4871-9E50-831DE8F03684 @default.
- Q61448032 P2093 Q61448032-3BBAA39D-2235-480F-99E1-13E2B8A78D64 @default.
- Q61448032 P2093 Q61448032-61928671-E83F-4D54-A7A5-C50E6E297013 @default.
- Q61448032 P2093 Q61448032-621C5C2E-1060-44D3-BCDB-8F7F67082E85 @default.
- Q61448032 P2093 Q61448032-6ABDEC4E-B5B2-4EF0-AB5F-44206420F597 @default.
- Q61448032 P2093 Q61448032-7B4D37A4-D0B2-4DDD-B7FE-049B5E304BF8 @default.
- Q61448032 P2093 Q61448032-B4789A8A-BAB4-430B-B111-AE0F30E8BF96 @default.
- Q61448032 P275 Q61448032-b170b2bf-625c-45b2-89bf-714b846fa83e @default.
- Q61448032 P2860 Q61448032-13E4E2BF-A35A-449B-9838-7EE3DDCEC370 @default.
- Q61448032 P2860 Q61448032-192E0A54-EE0D-461C-90A3-8B5C1E3E7E37 @default.
- Q61448032 P2860 Q61448032-2B4B1D2E-25B1-4B72-80BF-E11693EF1E59 @default.
- Q61448032 P2860 Q61448032-2FEB15CD-5076-43B5-8208-3707099BD3CF @default.
- Q61448032 P2860 Q61448032-6CB4FD1D-A202-45FA-827E-713190A7AEF6 @default.
- Q61448032 P2860 Q61448032-732763D0-0A11-44D2-AD18-9BEE9A4C9353 @default.
- Q61448032 P2860 Q61448032-96E64BF1-4E21-4E26-AA2A-0E9F335B46DB @default.
- Q61448032 P2860 Q61448032-A8A07B1B-D43B-4E19-84C7-79D3490029AE @default.
- Q61448032 P2860 Q61448032-A95A6F65-558B-478C-A1A5-5385D317E3AC @default.
- Q61448032 P2860 Q61448032-C596E050-2E07-4F8A-BA04-263E1175C2C5 @default.
- Q61448032 P2860 Q61448032-CDF1AE6E-3502-4EA0-A024-BC29D3F6B5CF @default.
- Q61448032 P2860 Q61448032-D103FF82-C7D0-4F8A-A0E3-25C69D95C87E @default.
- Q61448032 P2860 Q61448032-D59B43CE-9F25-4C93-826D-AFDB28DFBFC6 @default.
- Q61448032 P304 Q61448032-819E34F5-2368-4899-ABBD-E3F856870A21 @default.
- Q61448032 P31 Q61448032-CBCD2F36-AD0B-4D61-834D-AD1D7E9333C8 @default.
- Q61448032 P356 Q61448032-92C05EA7-99B7-460F-B16F-0919EA3D83B5 @default.
- Q61448032 P407 Q61448032-C4C560FC-E396-49C8-A293-6FF146AD6BF1 @default.
- Q61448032 P478 Q61448032-980BAB13-EB77-4150-B7DD-BCDFB8E0C20F @default.
- Q61448032 P577 Q61448032-BC906C83-1455-462A-97C5-551D1E82A871 @default.
- Q61448032 P6216 Q61448032-7f58f2cf-d1b3-41f8-9d1c-7bdfe5aae1ed @default.
- Q61448032 P698 Q61448032-5A7DCE10-2467-4176-AF8D-E0DAC24542C5 @default.
- Q61448032 P921 Q61448032-6F3D36F2-76B3-4E61-929E-9573BBCE7939 @default.
- Q61448032 P921 Q61448032-C79FAD67-9CEE-4A74-8185-3F36FC0A1402 @default.
- Q61448032 P932 Q61448032-85167A88-B915-4FDF-9927-66CD9B291ADF @default.
- Q61448032 P356 CEOR.S185547 @default.
- Q61448032 P698 30679916 @default.
- Q61448032 P1433 Q5133862 @default.
- Q61448032 P1476 "Comparative analysis of US real-world dosing patterns and direct infusion-related costs for matched cohorts of rheumatoid arthritis patients treated with infliximab or intravenous golimumab" @default.
- Q61448032 P2093 "Diana Stetsovsky" @default.
- Q61448032 P2093 "Elisabetta Malangone-Monaco" @default.
- Q61448032 P2093 "Helen Varker" @default.
- Q61448032 P2093 "Lorie A Ellis" @default.
- Q61448032 P2093 "Maureen Kubacki" @default.
- Q61448032 P2093 "Raphael J DeHoratius" @default.
- Q61448032 P2093 "Shelly Kafka" @default.
- Q61448032 P275 Q18810331 @default.
- Q61448032 P2860 Q33362177 @default.
- Q61448032 P2860 Q34439990 @default.
- Q61448032 P2860 Q34500921 @default.
- Q61448032 P2860 Q36257543 @default.
- Q61448032 P2860 Q38476881 @default.
- Q61448032 P2860 Q38554045 @default.
- Q61448032 P2860 Q40305889 @default.
- Q61448032 P2860 Q40352456 @default.
- Q61448032 P2860 Q48956161 @default.
- Q61448032 P2860 Q55056965 @default.
- Q61448032 P2860 Q84284316 @default.
- Q61448032 P2860 Q85235423 @default.
- Q61448032 P2860 Q88542642 @default.
- Q61448032 P304 "99-110" @default.
- Q61448032 P31 Q13442814 @default.
- Q61448032 P356 "10.2147/CEOR.S185547" @default.
- Q61448032 P407 Q1860 @default.
- Q61448032 P478 "11" @default.
- Q61448032 P577 "2019-01-01T00:00:00Z" @default.
- Q61448032 P6216 Q50423863 @default.
- Q61448032 P698 "30679916" @default.
- Q61448032 P921 Q1519812 @default.
- Q61448032 P921 Q187255 @default.
- Q61448032 P932 "6338107" @default.